Schedule 13G ownership disclosure
ALTAMIRA THERAPEUTICS LTD
Common Shares, par value USD 0.002 per share · CUSIP: G0360L134
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 478,547.00 · Class: 9.99%
- Steven Boyd
Shares: 478,547.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-001302
- Form type
- SCHEDULE 13G/A
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership